{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioavailability", "dissolution", "hybrid microspheres", "modified-release tablets", "molecular modelling", "naproxen"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32021089", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "22"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.2147/DDDT.S232111"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2020"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Engineering of Naproxen Loaded Polymer Hybrid Enteric Microspheres for Modified Release Tablets: Development, Characterization, in silico Modelling and in vivo Evaluation.", "Pagination": {"StartPage": "27", "EndPage": "41", "MedlinePgn": "27-41"}, "Abstract": {"AbstractText": ["Naproxen (NP) is a non-steroidal anti-inflammatory drug with poor aqueous solubility and low oral bioavailability, which may lead to therapeutic failure. NP causes crucial GIT irritation, bleeding, and peptic and duodenal ulcers.", "This study aimed to engineer and characterize polymer hybrid enteric microspheres using an integrated (experimental and molecular modelling) approach with further development to solid dosage form with modified drug release kinetics and improved bioavailability.", "NP loaded polymer hybrid enteric microspheres (PHE-Ms) were fabricated by using a modified solvent evaporation technique coupled with molecular modelling (MM) approach. The PHE-Ms were characterized by particle size, distribution, morphology, crystallinity, EE, drug-polymer compatibility, and DSC. The optimized NP loaded PHE-Ms were further subjected to downstream procedures including tablet dosage form development, stability studies and comparative in vitro-in vivo evaluation.", "The hydrophobic polymer EUD-L100 and hydrophilic polymer HPMC-E5 delayed and modified drug release at intestinal pH while imparting retardation of NP release at gastric pH to diminish the gastric side effects. The crystallinity of the NP loaded PHE-Ms was established through DSC and P (XRD). The particle size for the developed formulations of PEH-Ms (M1-M5) was in the range from 29.06 \u00b17.3-74.31 \u00b1 17.7 \u03bcm with Span index values of 0.491-0.69, respectively. The produced NP hybrid microspheres demonstrated retarded drug release at pH 1.2 and improved dissolution at pH 6.8. The in vitro drug release patterns were fitted to various release kinetic models and the best-followed model was the Higuchi model with a release exponent \"n\" value > 0.5. Stability studies at different storage conditions confirmed stability of the NP loaded PHE-Ms based tablets (<i>P</i><0.05). The molecular modelling (MM) study resulted in adequate binding energy of co-polymer complex SLS-Eudragit-HPMC-Naproxen (-3.9 kcal/mol). In contrast to the NP (unprocessed) and marketed formulations, a significant increase in the C<sub>max</sub> of PHE-MT1 (44.41\u00b14.43) was observed.", "The current study concludes that developing NP loaded PHE-Ms based tablets could effectively reduce GIT consequences with restored therapeutic effects. The modified release pattern could improve the dissolution rate and enhancement of oral bioavailability. The MM study strengthens the polymer-drug relationship in microspheres."], "CopyrightInformation": "\u00a9 2020 Hameed et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Khyber Pakhtunkhwa 18800, Pakistan."}], "LastName": "Hameed", "ForeName": "Hajra Afeera", "Initials": "HA"}, {"Identifier": ["0000-0002-3464-5435"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Khyber Pakhtunkhwa 18800, Pakistan."}, {"Identifier": [], "Affiliation": "Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa."}, {"Identifier": [], "Affiliation": "Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA."}], "LastName": "Khan", "ForeName": "Shahzeb", "Initials": "S"}, {"Identifier": ["0000-0002-6953-7848"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Khyber Pakhtunkhwa, Pakistan."}], "LastName": "Shahid", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic & Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Ullah", "ForeName": "Riaz", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Central Laboratory, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Bari", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Central Laboratory, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Ali", "ForeName": "Syed Saeed", "Initials": "SS"}, {"Identifier": ["0000-0002-6978-3133"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates."}], "LastName": "Hussain", "ForeName": "Zahid", "Initials": "Z"}, {"Identifier": ["0000-0003-3596-1760"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, COMSATS University Islamabad, Abbottabad 22060, Pakistan."}], "LastName": "Sohail", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya 47500, Malaysia."}], "LastName": "Khan", "ForeName": "Shafi Ullah", "Initials": "SU"}, {"Identifier": ["0000-0001-6193-1237"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya 47500, Malaysia."}], "LastName": "Htar", "ForeName": "Thet Thet", "Initials": "TT"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Polymers"}, {"RegistryNumber": "0", "NameOfSubstance": "Tablets"}, {"RegistryNumber": "57Y76R9ATQ", "NameOfSubstance": "Naproxen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Drug Liberation"}, {"QualifierName": [], "DescriptorName": "Drug Stability"}, {"QualifierName": [], "DescriptorName": "Microspheres"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": ["chemistry"], "DescriptorName": "Naproxen"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polymers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tablets"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Auriemma G, Cerciello A, Aquino RP. NSAIDS: design and development of innovative oral delivery systems. Nonsteroidal Anti-Inflammatory Drugs. 2017;33."}, {"Citation": "Altman R, Bosch B, Brune K. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75(8):859\u2013877. doi:10.1007/s40265-015-0392-z", "ArticleIdList": ["10.1007/s40265-015-0392-z", "PMC4445819", "25963327"]}, {"Citation": "Mrsny RJ. Oral drug delivery research in Europe. J Control Rele. 2012;161(2):247\u2013253. doi:10.1016/j.jconrel.2012.01.017", "ArticleIdList": ["10.1016/j.jconrel.2012.01.017", "22342473"]}, {"Citation": "Tsume Y, Mudie DM, Langguth P. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 2014;57:152\u2013163. doi:10.1016/j.ejps.2014.01.009", "ArticleIdList": ["10.1016/j.ejps.2014.01.009", "PMC4112588", "24486482"]}, {"Citation": "Boyd BJ, Bergstr\u00f6m CA, Vinarov Z. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci. 2019;137:104967. doi:10.1016/j.ejps.2019.104967", "ArticleIdList": ["10.1016/j.ejps.2019.104967", "31252052"]}, {"Citation": "Kansara H, Panola R, Mishra A. Techniques used to enhance bioavailability of BCS class II drugs: a review. Int J Drug Dev Res. 2015;7(1):82\u201393."}, {"Citation": "Zhao X, Song K, Wang S. Micronization of the pharmaceutically active agent genipin by an antisolvent precipitation process. Chem Eng Technol. 2013;36(1):33\u201342. doi:10.1002/ceat.201200036", "ArticleIdList": ["10.1002/ceat.201200036"]}, {"Citation": "Montes A, Kin N, Gordillo M. Polymer\u2013naproxen precipitation by supercritical antisolvent (SAS) process. J Supercritc Fluids. 2014;89:58\u201367. doi:10.1016/j.supflu.2014.02.004", "ArticleIdList": ["10.1016/j.supflu.2014.02.004"]}, {"Citation": "Alhnan MA, Basit AW. In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug\u2013polymer interactions. J Pharm Sci. 2011;100(8):3284\u20133293. doi:10.1002/jps.22572", "ArticleIdList": ["10.1002/jps.22572", "21500197"]}, {"Citation": "Wise DL. Handbook of Pharmaceutical Controlled Release Technology. CRC Press; 2000."}, {"Citation": "Liu F, Lizio R, Meier C. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine. J Control Rel. 2009;133(2):119\u2013124. doi:10.1016/j.jconrel.2008.09.083", "ArticleIdList": ["10.1016/j.jconrel.2008.09.083", "18930772"]}, {"Citation": "Moustafine R, Bukhovets A, Sitenkov A. Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers. Mol Pharm. 2013;10(7):2630\u20132641. doi:10.1021/mp4000635", "ArticleIdList": ["10.1021/mp4000635", "23777284"]}, {"Citation": "McGettigan P, Henry D. Current problems with non-specific COX inhibitors. Current Pharm Des. 2000;6(17):1693\u20131724. doi:10.2174/1381612003398690", "ArticleIdList": ["10.2174/1381612003398690", "11102559"]}, {"Citation": "Arroyo\u2010Lira AG, Rodr\u00edguez\u2010Ramos F, Ortiz MI. Supra\u2010additive interaction of docosahexaenoic acid and naproxen and gastric safety on the formalin test in rats. Drug Deve Res. 2017;78(7):332\u2013339. doi:10.1002/ddr.21396", "ArticleIdList": ["10.1002/ddr.21396", "28771757"]}, {"Citation": "Correa MA, Scarpa M, Franzini M. On the incorporation of the non-steroidal anti-inflammatory naproxen into cationic O/W microemulsions. Colloids Sur Biointerfaces. 2005;43(2):108\u2013114. doi:10.1016/j.colsurfb.2005.04.005", "ArticleIdList": ["10.1016/j.colsurfb.2005.04.005", "15919187"]}, {"Citation": "Guo Z, Liu X-M ML. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement. Colloids Sur Biointerfaces. 2013;101:228\u2013235. doi:10.1016/j.colsurfb.2012.06.026", "ArticleIdList": ["10.1016/j.colsurfb.2012.06.026", "23010024"]}, {"Citation": "Maghsoodi M, Taghizadeh O, Martin GP. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Int J Pharm. 2008;351(1\u20132):45\u201354. doi:10.1016/j.ijpharm.2007.09.033", "ArticleIdList": ["10.1016/j.ijpharm.2007.09.033", "17980983"]}, {"Citation": "Maheswari P, Rambhau D, Narasu M. Micellar solubilization in the formulation development of poorly soluble naproxen. Pharm Reg Affairs. 2013;2(108):2."}, {"Citation": "Aabakken L, Ugstad M, Gamst O. Naproxen-associated gastroduodenal toxicity: enteric coated granules versus plain tablets. Eur J Rheum Inflam. 1992;12(2):43\u201348.", "ArticleIdList": ["1364939"]}, {"Citation": "Adibkia K, Barzegar-Jalali M, Maheri-Esfanjani H. Physicochemical characterization of naproxen solid dispersions prepared via spray drying technology. Powder Technol. 2013;246:448\u2013455. doi:10.1016/j.powtec.2013.05.044", "ArticleIdList": ["10.1016/j.powtec.2013.05.044"]}, {"Citation": "Liu X, Zhou L, Zhang F. Reactive melt extrusion to improve the dissolution performance and physical stability of naproxen amorphous solid dispersions. Mol Pharm. 2017;14(3):658\u2013673. doi:10.1021/acs.molpharmaceut.6b00960", "ArticleIdList": ["10.1021/acs.molpharmaceut.6b00960", "28135108"]}, {"Citation": "Rahman MA, Ahmed N, Hasan I. Formulation and in vitro assessment of Eudragit L 100 and Eudragit S 100 based naproxen microspheres. Dhaka Univ J Pharm Sci. 2016;15(1):47\u201355. doi:10.3329/dujps.v15i1.29192", "ArticleIdList": ["10.3329/dujps.v15i1.29192"]}, {"Citation": "McConnell EL, Short MD, Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J Controll Rele. 2008;130(2):154\u2013160. doi:10.1016/j.jconrel.2008.05.022", "ArticleIdList": ["10.1016/j.jconrel.2008.05.022", "18639950"]}, {"Citation": "Obeidat WM, Price JC. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method. J Microencapsul. 2006;23(2):195\u2013202. doi:10.1080/02652040500435337", "ArticleIdList": ["10.1080/02652040500435337", "16754375"]}, {"Citation": "Al-Nasi AA, Al-Tahami KA. Preparation, characterization, and in vitro release of ketoprofen loaded polymeric microspheres. Int J PharmTech Res. 2016;9:313\u2013321."}, {"Citation": "Zaghloul A, Faltinek J, Vaithiyalingam S. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets. Pharmazie. 2001;56(4):321\u2013324.", "ArticleIdList": ["11338673"]}, {"Citation": "Krieger E, Vriend G, Spronk C. YASARA\u2013yet another scientific artificial reality application. YASARA Org. 2013;993."}, {"Citation": "Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Bio. 2015;1263:243\u2013250.", "ArticleIdList": ["25618350"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u2013461. doi:10.1002/jcc.21334", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Pettersen EF, Goddard TD, Huang CC. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u20131612. doi:10.1002/jcc.20084", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Pati\u00f1o\u2010Camacho SI, Moreno MGL, Flores\u2010Murrieta FJ. The pharmacokinetic profile of the combination of naproxen and tizanidine in rat. Drug Deve Res. 2013;74(1):31\u201337. doi:10.1002/ddr.21053", "ArticleIdList": ["10.1002/ddr.21053"]}, {"Citation": "Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Rele. 2005;102(2):313\u2013332. doi:10.1016/j.jconrel.2004.10.015", "ArticleIdList": ["10.1016/j.jconrel.2004.10.015", "15653154"]}, {"Citation": "Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 2008;363(1\u20132):26\u201339. doi:10.1016/j.ijpharm.2008.07.018", "ArticleIdList": ["10.1016/j.ijpharm.2008.07.018", "18706988"]}, {"Citation": "Alhalaweh A, Andersson S, Velaga SP. Preparation of zolmitriptan\u2013chitosan microparticles by spray drying for nasal delivery. Eur J Pharm Sci. 2009;38(3):206\u2013214. doi:10.1016/j.ejps.2009.07.003", "ArticleIdList": ["10.1016/j.ejps.2009.07.003", "19616094"]}, {"Citation": "Sharmin Akhter SP, Hasan I, Ayon NJ. Preparation, characterization and compatibility studies of naproxen loaded microspheres of cellulosic and polymethacrylic polymeric blend. Dhaka Univ J Phar Sci. 2013;12:11\u201321. doi:10.3329/dujps.v12i1.16295", "ArticleIdList": ["10.3329/dujps.v12i1.16295"]}, {"Citation": "Zhou D, Zhu X, Wang Y. Preparation and characterization of a novel pH-sensitive coated microsphere for duodenum-specific drug delivery. Arch Pharm Res. 2012;35(5):839\u2013850. doi:10.1007/s12272-012-0509-9", "ArticleIdList": ["10.1007/s12272-012-0509-9", "22644851"]}, {"Citation": "Montes A, Bendel A, K\u00fcrti R. Processing naproxen with supercritical CO2. J Supercritic Fluids. 2013;75:21\u201329. doi:10.1016/j.supflu.2012.12.016", "ArticleIdList": ["10.1016/j.supflu.2012.12.016"]}, {"Citation": "Dixit M, Kulkarni P, Charyulu R. Enhancing solubility and dissolution of naproxen by spray drying technique. World J Pharm Pharma Sci. 2015;4:715\u2013725."}, {"Citation": "Varshosaz J, Khajavinia A, Ghasemlu M. Enhancement in dissolution rate of piroxicam by two micronization techniques. Dissolution Technol. 2013;20(3):15\u201323. doi:10.14227/DT200313P15", "ArticleIdList": ["10.14227/DT200313P15"]}, {"Citation": "Mouffok M, Mesli A, Abdelmalek I. Effect of the formulation parameters on the encapsulation efficiency and release behavior of p-aminobenzoic acid-loaded ethylcellulose microspheres. J Serb Chem Soc. 2016;81(10):1183\u20131198. doi:10.2298/JSC160308068M", "ArticleIdList": ["10.2298/JSC160308068M"]}, {"Citation": "Jyothi NVN, Prasanna PM, Sakarkar SN. Microencapsulation techniques, factors influencing encapsulation efficiency. J Microencapsul. 2010;27(3):187\u2013197. doi:10.3109/02652040903131301", "ArticleIdList": ["10.3109/02652040903131301", "20406093"]}, {"Citation": "Ahmed S, Govender T, Khan I. Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity. Drug Des Dev Ther. 2018;12:255. doi:10.2147/DDDT.S148912", "ArticleIdList": ["10.2147/DDDT.S148912", "PMC5804124", "29440875"]}, {"Citation": "Ndlovu ST, Ullah N, Khan S. Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction. Drug Deliv Trans Res. 2019;9(1):284\u2013297. doi:10.1007/s13346-018-00596-w", "ArticleIdList": ["10.1007/s13346-018-00596-w", "30387048"]}, {"Citation": "Seedat N, Kalhapure RS, Mocktar C. Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid\u2013polymer hybrid nanoparticles: in vitro and in silico studies. Mater Sci Eng. 2016;61:616\u2013630. doi:10.1016/j.msec.2015.12.053", "ArticleIdList": ["10.1016/j.msec.2015.12.053", "26838890"]}, {"Citation": "Nandhakumar S, Alekya C. Formulation and optimization of delayed release MUPS (Multiple Unit Particulate System) tablets of omeprazole. Mater Sci. 2017."}, {"Citation": "Mundargi RC, Shelke NB, Rokhade AP. Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin. Carbohydr Polym. 2008;71(1):42\u201353. doi:10.1016/j.carbpol.2007.05.013", "ArticleIdList": ["10.1016/j.carbpol.2007.05.013"]}, {"Citation": "Al-Hashimi N, Begg N, Alany R. Oral modified release multiple-unit particulate systems: compressed pellets, microparticles and nanoparticles. Pharm. 2018;10(4):176.", "ArticleIdList": ["PMC6321440", "30287798"]}, {"Citation": "Maghsoodi M. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit L100. AAPS Pharm Sci Tech. 2009;10(1):120. doi:10.1208/s12249-009-9186-5", "ArticleIdList": ["10.1208/s12249-009-9186-5", "PMC2663676", "19184624"]}, {"Citation": "Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395(1\u20132):44\u201352. doi:10.1016/j.ijpharm.2010.05.003", "ArticleIdList": ["10.1016/j.ijpharm.2010.05.003", "20546856"]}, {"Citation": "Qiu Y, Zhou D. Understanding design and development of modified release solid oral dosage forms. J Validation Technol. 2011;17(2):23."}, {"Citation": "Sangalli M, Maroni A, Foppoli A. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. Eur J Pharm Sci. 2004;22(5):469\u2013476. doi:10.1016/j.ejps.2004.05.002", "ArticleIdList": ["10.1016/j.ejps.2004.05.002", "15265517"]}, {"Citation": "Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Rele. 1987;5(1):37\u201342. doi:10.1016/0168-3659(87)90035-6", "ArticleIdList": ["10.1016/0168-3659(87)90035-6", "25356469"]}, {"Citation": "Peppas N. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helvetiae. 1985;60(4):110\u2013111.", "ArticleIdList": ["4011621"]}, {"Citation": "Shah S, Madan S, Agrawal S. Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl. DARU J Pharm Sci. 2012;20(1):24. doi:10.1186/2008-2231-20-24", "ArticleIdList": ["10.1186/2008-2231-20-24", "PMC3555840", "23351176"]}]}], "History": [{"Year": "2019", "Month": "9", "Day": "23"}, {"Year": "2019", "Month": "12", "Day": "13"}, {"Year": "2020", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["32021089", "PMC6954845", "10.2147/DDDT.S232111", "232111"]}}]}